Nykredit A/S’s Bristol-Myers Squibb BMY Stock Holding History

Nykredit A/S’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.2M	Buy	+506,199	New	+$29.1M	0.09%	179

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Nykredit A/S's BMY Position: Q2 2026 in Review

Nykredit A/S opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 506,199 shares worth $29.2M. The stake represents 0.09% of the portfolio and ranks #179 among its holdings.

2,142 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Nykredit A/S held 506,199 shares of Bristol-Myers Squibb worth $29.2M as of Q2 2026.
Bristol-Myers Squibb was a new Nykredit A/S position in Q2 2026.
Bristol-Myers Squibb made up 0.09% of Nykredit A/S's portfolio in Q2 2026, its #179 holding.
2,142 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.